赵
赵义勇 Cadre supérieur
Other
FR FR · AMF
Discover the full record of transactions filed by 赵义勇, Cadre supérieur. Director active across 1 companies, notably 万泰生物. In total, 21 reports have been published. The latest transaction was disclosed on 28 May 2025 — Sale. Regulator: AMF. All data is openly available.
Declarations 21 total
Executives ● Sale万 万泰生物 11 SSE €839,514 99,300 shares
SSE:173000008994461820 · 28 May 2025
Executives ● Sale万 万泰生物 11 SSE €91,752 10,000 shares
SSE:173000008467329820 · 20 Jan 2025
Executives ● Sale万 万泰生物 11 SSE 24,800 shares
SSE:173000006045106720 · 15 Nov 2022
Executives ● Sale万 万泰生物 11 SSE 5,300 shares
SSE:173000005476061380 · 26 Apr 2022
Executives ● Sale万 万泰生物 11 SSE 1,500 shares
SSE:173000005447273440 · 19 Apr 2022
Executives ● Sale万 万泰生物 11 SSE 5,000 shares
SSE:173000005410668060 · 31 Mar 2022
Executives ● Sale万 万泰生物 11 SSE 10,000 shares
SSE:173000005380692770 · 23 Mar 2022
Executives ● Sale万 万泰生物 11 SSE 214,700 shares
SSE:173000005154507780 · 9 Dec 2021
Executives ● Purchase万 万泰生物 7 SSE 100 shares
SSE:173000004826371970 · 8 Sept 2021
Ideal exit: 5 Jun 2022 (T+270) Executives ● Sale万 万泰生物 11 SSE 59,840 shares
SSE:173000004478247680 · 11 Jun 2021
Executives ● Sale万 万泰生物 11 SSE 33,900 shares
SSE:173000004478511040 · 10 Jun 2021
108,280 shares
SSE:173000004475138600 · 10 Jun 2021
Executives ● Sale万 万泰生物 11 SSE 109,000 shares
SSE:173000004475138530 · 10 Jun 2021
11,800 shares
SSE:173000004467087360 · 8 Jun 2021
2,300,000 shares
SSE:173000004467262240 · 8 Jun 2021
Executives ● Sale万 万泰生物 11 SSE 14,600 shares
SSE:173000004470430900 · 8 Jun 2021
Executives ● Sale万 万泰生物 11 SSE 58,120 shares
SSE:173000004467262750 · 7 Jun 2021
69,920 shares
SSE:173000004464638720 · 4 Jun 2021
Executives ● Sale万 万泰生物 11 SSE 98,200 shares
SSE:173000004464923550 · 4 Jun 2021
Executives ● Sale万 万泰生物 11 SSE 600,000 shares
SSE:173000004439383580 · 26 May 2021
Executives ● Sale万 万泰生物 11 SSE 180,000 shares
SSE:173000004430271650 · 21 May 2021
About 赵义勇 赵义勇 is a Senior Executive at 万泰生物. He oversees operations and contributes to the company's strategy. 万泰生物 is a major player in the biopharmaceutical sector, and 赵义勇's experience is essential for its development.